Don't so happy ba. Profit is from unrealized profit from xox stocks, which pp at 0.05, and sep price is around 0.15. that's y paper gain rm36mil. Now xox price is just 0.1, next q already negative rm18mil from investment already.
The profit maybe from selling partial of their share in xox when the price spike. Then they buy again at around 0.11, surely after xox right issue the price will spike again. Clever investor. Like chin hin buying share in solarvest. Before they sell their share the profit it will not be in their QR.
Kgroup is not only the company who can deal with medical field including covid test kit. It is also the company who can provide one stop solution by having its intelligence software technology such as data system etc. This is very important to enhance the entire system in our medical field especially during current fighting with covid
Seems many sellers not too happy with the qr report, big profit but the price also stagnant, must report big loss only move faster...move downwards for few days.
Healthcare, construction, tech stocks seen to be on uptrend on higher development expenditure TheEdge Fri, Nov 27, 2020 10:54am - 8 hours ago
KUALA LUMPUR (Nov 27): Local stocks showed an upward momentum as Budget 2021 was passed with a voice vote at the policy stage in Parliament yesterday after heated debates.
Malacca Securities, in its equity note, said the approval would favour the construction sector as a proxy to the budget amid the higher development expenditure.
"The healthcare will continue to fare better, while the technology sector is expected to remain upbeat as the recent batch of corporate earnings remained solid," it said.
Under Budget 2021, the government has allocated RM322.5 billion for development expenditure (DE) which will continue to be channelled to programmes and projects with high multiplier effects to promote economic growth and support the livelihood of the rakyat.
The health sub-sector remains a priority, as it will receive an allocation of RM4.7 billion or 6.8% of total DE.
Bright future for Kgroup's new venture into medical businesses. The share prices surely will fly to the sky once Kgroup's medical devices and products fully in operation soon. Buy and keep now while the share price still cheap, you'll not regret your investment later.
In addition, KASB has received indicative queries from various third-party agencies looking to distribute to medical facilities, GLCs and other government agencies, amounting to 500,000 test kits. KASB is currently in discussions with various parties on concrete commercial agreements and will update the market accordingly.
Minimum rm 15 mil profit just from these kits. Problem now I guess is logistics.
The Gov wants 3 million test done on the foreign workers before the year ends
No worries la show yet to come i guess. Recall last week huge volume but no price surge? Possibly volume collecting @5.5. So will those boys collect for nothing?
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
CKT1818
331 posts
Posted by CKT1818 > 2020-11-26 17:30 | Report Abuse
Earnings per share - RM0.0374
Net asset per share - RM0.1277
Fair value share price - RM0.165
This should be the price based on 3QR!!